Autopsy report · NCT00518245

Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)

“Low rate of patient recruitment. Cannot achieve sample size.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years before it stopped.
• 11 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Canadian Heart Research Centre

Sponsor type

University, hospital or other

Conditions

Unstable Angina

Interventions

enoxaparin

Participants

11

Sites

1

Countries

Canada

Trials that died the same way

• Pleural Suction Additional to Thoracostomy Tube for Traumatic Hemothorax
  “It was not possible to achieve adequate recruitment to complete the necessary sample. The rate at which patients are recruited does not allow for continued participation” (80% match in meaning)
• Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia
  “Patient recruitment insufficient” (80% match in meaning)
• Ethibond Suture vs Vessel Loop as Draining Seton for Complex Anal Fistulas
  “Unable to recruit the required number of patients as per the sample size calculated” (79% match in meaning)
• Fesoterodine on Urgency Episodes in Parkinson's Disease Population
  “Insufficient or untimely patient recruitment” (78% match in meaning)
• Daptomycin in Pediatric Patients With Bacterial Meningitis
  “Insufficient patient recruitment” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.